Cannabis has a long history of being used for a variety of purposes, from hemp oils and fibres to medicinal purposes. It became acknowledged and accepted into American pharmacopoeia, where it was evaluated for treating diseases, or the accompanying symptoms, until the early 1940s. […]
Last week, the Republican debate took a turn to focus on marijuana laws in the US. Moderator Jake Tapper took to a question popular on social media, asking about candidates views on marijuana legalization. He quoted Governor Christie, who recently said ‘if you’re getting high in Colorado today,’ where marijuana has been legalized, ‘enjoy it until January 2017, Read more about The Politics Of Medical Marijuana Takes Front Stage[…]
In Mexico City, 8 year old Graciela Elizalde lives with a rare disease that makes her suffer from up to 400 epileptic convulsions every day. Despite having to endure surgery and seeking out alternative treatments, her epileptic fits “have greatly grown in intensity, force, and frequency” her mother said. […]
This week in Georgia, public health officials reported that nearly 200 patients now qualified for the state’s new medical marijuana registry. This also includes an increase in the number of doctors now approved to recommend cannabis oil as a treatment. […]
Last Friday, Michigan’s Medical Marijuana Review Panel voted to add autism to the list of qualifying conditions fit for treatment under state law.
Mike Zimmer, director of the Michigan Department of Licensing and Regulatory Affairs, is the next step in the process for approval. Zimmer has until late October to make a final decision. Once a final determination is made it will be announced on the agency’s website. […]
Over the past few months, from local community halls to Capitol Hill, one thing has been made clear: there is an outcry of support in favor of more research on CBD and medical marijuana. Proponents of CBD oil state that removing these barriers to research is the only clear way to market something so significant to families around the world.
Earlier this year, Democrat Sen. Diane Feinstein (CA) and Republican Sen. Charles Grassley (IA) urged the Obama administration to “definitively determine if CBD has scientific and medical benefits,” and to “look at expanding compassionate access programs where possible, to benefit as many children as possible.”
Recently, support has also come out from the director of the US National Institute on Drug Abuse (NIDA), Nora Volkow. Volkow believes that cannabidiol (CBD) – a nonpsychotropic cannabinoid – is “a safe drug with no addictive effects.” In a column with The Huffington Post, she further stated that“[P]reliminary data suggest that it may have therapeutic value for a number of medical conditions.”
With all of the talk going on around the country, is there any action behind these promises? […]